Literature DB >> 20621644

A 90-day oral toxicity study of nisin A, an anti-microbial peptide derived from Lactococcus lactis subsp. lactis, in F344 rats.

Akihiro Hagiwara1, Norio Imai, Hironao Nakashima, Yosuke Toda, Mayumi Kawabe, Fumio Furukawa, Joss Delves-Broughton, Kazuo Yasuhara, Shim-Mo Hayashi.   

Abstract

This study was designed to evaluate and characterize any adverse effect of nisin A, when administered to both sexes of F344/DuCrlCrlj rats (10 males and 10 females in each group) at dietary levels of 0%, 0.2%, 1.0% and 5.0% for 90 days. Animals given NaCl at a dietary level of 3.712% (equivalent to the NaCl content in 5.0% nisin A diet) served as a reference material treated group. There were no deaths, and the treatment had no toxicologically significant effects on clinical signs, body weights, food consumption, ophthalmology, hematology, or gross pathology. Statistically significant increases of water consumption, urine volume, and urinary sodium and chlorine, and decreases of urinary potassium and serum sodium, along with increases of absolute and relative kidney weight, and incidences of minimal squamous cell hyperplasia of limiting ridge in the forestomach, were found in nisin A-treated groups. It was considered that these changes were related to NaCl, since they were also noted in rats given diet containing the reference substance. Thus, no toxicologically significant changes were apparent in both sexes of F344/DuCrlCrlj rats fed diet containing 0%, 0.2%, 1.0% and 5.0% nisin A for 90 days. Therefore, the no-observed-adverse-effect level (NOAEL) for nisin A was concluded to be a dietary level of 5.0% (2996 mg/kg/day for males and 3187 mg/kg/day for females). Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20621644     DOI: 10.1016/j.fct.2010.06.002

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  7 in total

1.  The physiological response of broiler chickens to the dietary supplementation of the bacteriocin nisin and ionophore coccidiostats.

Authors:  B Kieronczyk; M Sassek; E Pruszynska-Oszmalek; P Kolodziejski; M Rawski; S Swiatkiewicz; D Józefiak
Journal:  Poult Sci       Date:  2017-09-01       Impact factor: 3.352

2.  Suicin 3908, a new lantibiotic produced by a strain of Streptococcus suis serotype 2 isolated from a healthy carrier pig.

Authors:  Katy Vaillancourt; Geneviève LeBel; Michel Frenette; Marcelo Gottschalk; Daniel Grenier
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

3.  Assessment of anti-plasmodial activity of non-hemolytic, non-immunogenic, non-toxic antimicrobial peptides (AMPs LR14) produced by Lactobacillus plantarum LR/14.

Authors:  Ruchi Gupta; Vinoth Rajendran; Prahlad C Ghosh; Sheela Srivastava
Journal:  Drugs R D       Date:  2014-06

4.  In vivo activity of nisin A and nisin V against Listeria monocytogenes in mice.

Authors:  Alicia Campion; Pat G Casey; Des Field; Paul D Cotter; Colin Hill; R Paul Ross
Journal:  BMC Microbiol       Date:  2013-02-01       Impact factor: 3.605

5.  Comparative Evaluation of the Antimicrobial Activity of Different Antimicrobial Peptides against a Range of Pathogenic Bacteria.

Authors:  Anna Ebbensgaard; Hanne Mordhorst; Michael Toft Overgaard; Claus Gyrup Nielsen; Frank Møller Aarestrup; Egon Bech Hansen
Journal:  PLoS One       Date:  2015-12-11       Impact factor: 3.240

6.  Oral Delivery of Nisin in Resistant Starch Based Matrices Alters the Gut Microbiota in Mice.

Authors:  Ronan Gough; Raúl Cabrera Rubio; Paula M O'Connor; Fiona Crispie; André Brodkorb; Song Miao; Colin Hill; Reynolds P Ross; Paul D Cotter; Kanishka N Nilaweera; Mary C Rea
Journal:  Front Microbiol       Date:  2018-06-15       Impact factor: 5.640

7.  Bacteriocins as a new generation of antimicrobials: toxicity aspects and regulations.

Authors:  Samira Soltani; Riadh Hammami; Paul D Cotter; Sylvie Rebuffat; Laila Ben Said; Hélène Gaudreau; François Bédard; Eric Biron; Djamel Drider; Ismail Fliss
Journal:  FEMS Microbiol Rev       Date:  2021-01-08       Impact factor: 16.408

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.